ArticleCureus2026
Acute-Onset Iron Overload Cardiomyopathy in Diamond-Blackfan Anaemia: A Case Report of Rapid Ejection Fraction Decline.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diamond-Blackfan anaemia (DBA) is a rare inherited bone marrow failure syndrome causing pure red cell aplasia. Patients frequently require long-term red cell transfusions, predisposing them to iron overload. This case describes a patient with DBA with rapid ejection fraction decline secondary to acute-onset iron overload cardiomyopathy. A 28-year-old male patient with known transfusion-dependent DBA and established iron overload and on deferasirox, presented with a one-week history of orthopnoea, dyspnoea and peripheral oedema. Echocardiography demonstrated severe biventricular impairment with an ejection fraction of 15-25%. This represented a marked decline from an estimated ejection fraction of 45% two years prior. His course was then complicated by fast atrial fibrillation and severe refractory hypokalaemia, leading to escalation to the critical care unit. Cardiac MRI confirmed significant myocardial and hepatic iron loading. He was then managed with intravenous deferrioxamine, heart failure pharmacotherapy and rate control, with subsequent escalation of oral chelation. He was then discharged with combined cardiology and haematology follow-up. This case illustrates a severe complication of DBA: acute-onset iron overload cardiomyopathy causing rapid ejection fraction decline despite ongoing oral chelation. Markedly elevated ferritin, transferrin saturation and serum iron, alongside a normal CRP, supported a diagnosis of severe systemic iron overload. Management required a rapid switch from oral deferasirox to intravenous desferrioxamine. This case demonstrates that severe, acute iron overload cardiomyopathy can occur in patients with transfusion-dependent DBA despite ongoing chelation. It supports the value of further study of cardiac outcomes in this patient group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.